Real-world experience with belantamab mafodotin therapy for relapsed/refractory multiple myeloma: a multi-center retrospective study

被引：0

作者：

Shragai, Tamir ^{[1
]}

Magen, Hila ^{[2
]}

Lavi, Noa ^{[3
]}

Gatt, Moshe ^{[4
]}

Trestman, Svetlana ^{[1
]}

Zektser, Miri ^{[5
]}

Ganzel, Chezi ^{[6
]}

Jarchowsky, Osant ^{[7
]}

Berger, Tamar ^{[8
]}

Tadmor, Tamar ^{[9
]}

Leiba, Merav ^{[10
]}

Hertzog-Zarfaty, Katrin ^{[11
]}

Horowitz, Netanel ^{[3
]}

Shapira, Michael ^{[12
]}

Varssano, David ^{[1
]}

Berger, Yoav ^{[2
]}

Frenkel, Shahar ^{[4
]}

Krauthammer, Mark ^{[1
]}

Avivi, Irit ^{[13
,14
]}

Luttwak, Efrat ^{[1
]}

Cohen, Yael ^{[13
,14
]}

机构：

[1] Tel Aviv Sourasky Med Ctr, Tel Aviv, Israel

[2] Sheba Med Ctr, Ramat Gan, Israel

[3] Rambam Hlth Care Campus, Haifa, Israel

[4] Hadassah Med Ctr, Jerusalem, Israel

[5] Soroka Univ Hosp, Beer Sheva, Israel

[6] Shaare Zedek Med Ctr, Jerusalem, Israel

[7] Meir Med Ctr, Kefar Sava, Israel

[8] Rabin Med Ctr, Petah Tiqwa, Israel

[9] Bnei Zion Med Ctr, Haifa, Israel

[10] Assuta Ashdod Med Ctr, Ashdod, Israel

[11] Shamir Med Ctr, Beer Yaagov, Israel

[12] Assuta Ramat HaChayal Hosp, Tel Aviv, Israel

[13] Tel Aviv Sourasky Ichilov Med Ctr, Tel Aviv, Israel

[14] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2022年 / 22卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P-114

引用

页码：S98 / S98

页数：1

共 50 条

[41] Phase I/II Study of Belantamab Mafodotin, Cyclophosphamide, and Dexamethasone (BelCyd) in Relapsed/Refractory Multiple Myeloma
Badros, Ashraf Z.
Nash, Thea
Lawrance, Christopher
Tittle, Brandon
Philip, Sunita
Sunshine, Sarah
Munir, Wuqaas
Fan, Xiaoxuan
Ide, Christina
Atanackovic, Djordje
BLOOD, 2023, 142
[42] Ocular Toxicity of Belantamab Mafodotin, an Oncological Perspective of Management in Relapsed and Refractory Multiple Myeloma
Wahab, Ahsan
Rafae, Abdul
Mushtaq, Kamran
Masood, Adeel
Ehsan, Hamid
Khakwani, Maria
Khan, Aqsa
FRONTIERS IN ONCOLOGY, 2021, 11
[43] Bortezomib therapy in a real-world setting in patients with relapsed or refractory multiple myeloma
Huang, Shang-Yi
Chen, Tsai-Yun
Kuo, Ching-Yuan
Chen, Yeu-Chin
Lin, Sheng-Fung
Chang, Ming-Chih
Lv, Xinzhu
Yang, Betty
Chang, Cheng-Shyong
ONCOLOGY REVIEWS, 2019, 13 (01) : 15 - 22
[44] The efficacy and safety of pomalidomide in relapsed/refractory multiple myeloma in a "real-world" study: Polish Myeloma Group experience
Charlinski, Grzegorz
Grzasko, Norbert
Jurczyszyn, Artur
Janczarski, Mariusz
Szeremet, Agnieszka
Waszczuk-Gajda, Anna
Bernatowicz, Pawel
Swiderska, Alina
Guzicka-Kazimierczak, Renata
Lech-Maranda, Ewa
Szczepaniak, Andrzej
Wichary, Ryszard
Dmoszynska, Anna
EUROPEAN JOURNAL OF HAEMATOLOGY, 2018, 101 (03) : 354 - 361
[45] Carfilzomib, Pomalidomide, Dexamethasone with and without Daratumumab in Relapsed/Refractory Multiple Myeloma: A Multi-Center, Prospective Real World Study in China
Zhang, Fujing
Wang, Wei
Wang, Hua
Wang, Wei
Liu, Aijun
Tian, Weiwei
Qin, Xiaoqi
Xia, Zhongjun
Zhuang, Junling
BLOOD, 2024, 144 : 6985 - 6986
[46] Real-world outcome and healthcare costs of relapsed or refractory multiple myeloma: A retrospective analysis from the Chinese experience
Zhou, Xin
Xia, Jun
Mao, Jingjue
Cheng, Feng
Qian, Xifeng
Guo, Hongfeng
HEMATOLOGY, 2016, 21 (05) : 280 - 286
[47] Real-world experience of KPD use in relapsed or refractory myeloma
Barrett, A.
Gul, F.
Nee, A.
O'Leary, H.
O'Keefe, D.
BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 : 238 - 238
[48] “Real-life” data of the efficacy and safety of belantamab mafodotin in relapsed multiple myeloma—the Mayo Clinic experience
I. Vaxman
J. Abeykoon
A. Dispenzieri
S. K. Kumar
F. Buadi
M. Q. Lacy
D. Dingli
Y. Hwa
A. Fonder
M. Hobbs
C. Reeder
T. Sher
S. Hayman
T. Kourelis
R. Warsame
E. Muchtar
N. Leung
R. Go
W. Gonsalves
M. Siddiqui
R. A. Kyle
S. V. Rajkumar
McCullough Kristen
P. Kapoor
M. A. Gertz
Blood Cancer Journal, 11
[49] Compassionate Use of Belantamab Mafodotin for Treatment of Patients with Relapsed/Refractory Multiple Myeloma Heavily Treated. Spanish Experience
Alegre, Adrian
Benzo Callejo, Gonzalo
Alonso Fernandez, Rafael
Martinez-Lopez, Joaquin
Jimenez-Ubieto, Ana
Cuellar, Clara
Askari, Elham
Prieto, Elena
Alaez, Concha
Aguado, Beatriz
Velasco, Alberto
Krsnik, Isabel
Llorente, Laura
Munoz-Linares, Cristina
Morales, Ana
Gimenez Mesa, Eugenio
Iglesias, Rebeca
Martinez-Chamorro, Carmen
Alonso, Arancha
Jimenez-Montes, Carmen
Jesus Blanchard, Maria
BLOOD, 2021, 138 : 3775 - +
[50] Teclistamab for Relapsed/Refractory Multiple Myeloma: Real-World Experience in an Early Access Program
Uttervall, Katarina
Nahi, Hareth
Kashif, Muhammad
Lemonakis, Konstantinos
Rosengren, Sara
Brolin, Janaki
Lund, Johan
Hansson, Markus
BLOOD, 2022, 140 : 12605 - 12606

← 1 2 3 4 5 →